NEUROINFLAMMATION IN GLAUCOMA (PART 2)

 

Neuroinflammation in glaucoma is best understood as a chronic, spatially organized, and self-amplifying response to neuronal and axonal stress rather than as a conventional inflammatory reaction. The optic nerve head (ONH) is a major site at which multiple stressors converge.

Mechano-sensitive signaling and intracellular Ca2+ overload promote the extracellular release of adenosine triphosphate (ATP), which has a role in inflammation, as described subsequently.

Stressed RGCs, damaged axons, and dysfunctional mitochondria release damage-associated molecular patterns (DAMPs), including heat-shock proteins (HSPs), high-mobility group box 1 (HMGB1), mitochondrial DNA, oxidized proteins, and reactive oxygen species (ROS). These signals are detected by pattern-recognition receptors expressed by microglia, astrocytes, and Müller cells, particularly toll-like receptors (TLRs) and purinergic P2X7 receptors.

Toll-like receptors (TLRs), a pivotal subset of pattern recognition receptors (PRRs), serve as sentinels of the innate immune system by recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). In glaucomatous retina, TLR expression is markedly elevated. In vitro studies reveal that both HSPs and oxidative stress act as potent inducers of TLR expression, thereby amplifying the release of pro-inflammatory cytokines and immunostimulatory mediators that activate both innate and adaptive immune pathways. Notably, tenascin-C, an endogenous ligand for TLR4, is upregulated in glaucomatous ONH and has been shown to activate TLR4 signaling in arthritis. It is hypothesized that tenascin-C may initiate inflammation via TLR4 prior to DAMP release by injured RGCs.

TLR engagement activates MyD88- and TRIF-dependent signaling and the transcription factor NF-κB, whereas ATP-mediated P2X7 activation induces K+ efflux, ROS generation, and lysosomal destabilization, thereby promoting assembly of the NLRP3 inflammasome. Activated NLRP3 subsequently stimulates caspase-1-dependent maturation of IL-1β and IL-18, establishing an inflammatory feedback-loop that further increases glial activation and RGCs’ vulnerability. 

Microglia are among the earliest cellular responders to glaucomatous stress, and their activation may precede detectable RGC loss. Under physiological conditions, ramified microglia continuously survey the retinal microenvironment, remove cellular debris, regulate synaptic remodeling, and provide trophic support. During the early phases of injury, these functions may remain adaptive and contribute to tissue repair.

Persistent biomechanical, oxidative, or metabolic stress, however, induces a transition toward amoeboid, highly phagocytic, and pro-inflammatory states characterized by the release of TNF-α, IL-1β, IL-6, chemokines, nitric oxide, ROS, matrix metalloproteinases, and complement components.

Microglial signals also induce reactive changes in astrocytes and Müller cells, while astrocyte-derived mediators reciprocally regulate microglial migration, complement expression, and phagocytosis. Astrocytes can initially preserve tissue architecture, vascular-barrier integrity, metabolic support, and glutamate homeostasis; with prolonged reactivity, however, astrocytes reduce their neurotrophic and antioxidant support, remodel the extracellular matrix, and amplify inflammatory signaling through their extensive gap-junction networks.

Müller-cell dysfunction additionally impairs extracellular glutamate clearance, contributing to excitotoxicity. In this context, soluble glia-derived TNF-α provides a direct molecular link between neuroinflammation and excitotoxic RGC death by increasing the surface expression of Ca2+-permeable AMPA receptors, thereby promoting Ca2+ overload, mitochondrial dysfunction, and axonal cytoskeletal damage. These interactions can be integrated into a self-sustaining mitochondrial-neuroinflammatory closed loop.

Initial impairment of mitochondrial electron transport chain (ETC) function increases electron leakage and mitochondrial ROS production. ROS damage the mitochondrial proteins, lipids, and DNA, and promote the extracellular release of mitochondrial DNA, oxidized molecules, ATP, and other DAMPs. Recognition of these signals by microglial TLRs, P2X7 receptors, and inflammasome pathways reinforces microglial activation and the secretion of TNF-α and other inflammatory mediators.

TNF-α-driven NF-κB signaling can, in turn, impair mitochondrial biogenesis and respiratory-chain homeostasis, including reduced expression or function of ETC subunits, thereby worsening electron leakage, ATP failure, and ROS generation. The newly generated ROS and DAMPs re-enter the same pathway, converting an initially trigger-dependent response into a feed-forward cycle of mitochondrial failure and glial activation.

Glial activation & immune crosstalk in glaucoma

Once sufficiently established, this loop may persist after the initiating mechanical or ischemic stress has diminished and may become partly independent of external IOP. 

It therefore provides a mechanistic explanation for continuing degeneration in NTG and in patients who progress despite achieving target IOP, although the relative contribution of each link and the point at which the loop becomes autonomous remain to be established in human glaucoma.